Abhigyan Som

Title: Inventor Abhigyan Som: Innovations in Protein Transduction

Introduction

Abhigyan Som, an esteemed inventor based in Sunderland, MA, has made significant contributions to the field of synthetic biology. With a total of four patents to his name, Som is recognized for his innovative work on cell penetrating peptides, which has implications in various biological applications and therapeutic interventions.

Latest Patents

Among his most notable inventions are the patents related to protein transduction domain mimics. These inventions focus on creating synthetic mimics of cell penetrating peptides. Specifically, Som has developed novel monomers, oligomers, and co-polymers that are instrumental for the preparation of these synthetic mimics. His work highlights the importance of understanding the composition, preparation, and application of these novel compounds in enhancing biological delivery systems.

Career Highlights

Abhigyan Som is affiliated with the University of Massachusetts, where he works alongside a team of innovative researchers. His efforts in the field have contributed to advancing the understanding and development of cell penetrating peptides, reflecting his dedication to scientific research and innovation.

Collaborations

Throughout his career, Som has collaborated with notable colleagues, including Gregory N. Tew and Gregory J. Gabriel. These partnerships have fostered an environment of creativity and intellectual exchange, further enriching the advancements in their shared fields of expertise.

Conclusion

Abhigyan Som's work exemplifies the spirit of innovation that drives the scientific community forward. His contributions towards developing synthetic mimics of cell penetrating peptides not only showcase his inventive prowess but also highlight the potential applications of his patents in various sectors, including medicine and biotechnology. As he continues to push the boundaries of research at the University of Massachusetts, the impact of his work will likely resonate for years to come.